Collaboration with NIH Seven Bridges has a partnership with the National Institutes of Health (NIH) since 2020, working on the INCLUDE Project, opening doors for potential collaborations and sales opportunities within the research and healthcare sectors.

OmicCircos R shiny app launch The launch of the OmicCircos R shiny app by Seven Bridges on the Cancer Genomics Cloud platform showcases innovative solutions, creating avenues for selling bioinformatics tools and services to researchers and institutions in need of advanced genomics analysis.

Acquisition by Summa Equity Being acquired by Summa Equity and merged into Velsera, a new precision medicine company, positions Seven Bridges at a strategic advantage with potentially increased resources and market access for scaling up sales initiatives in the precision medicine field.

Unified Patient Network subsidiary launch The establishment of the Unified Patient Network (UPN) as a subsidiary by Seven Bridges fosters opportunities for collaboration between health systems and biopharma companies, presenting sales prospects for offering bioinformatics solutions tailored to clinical research and precision medicine advancements.

BCO standard development Seven Bridges' collaboration with the BioCompute Object (BCO) community to develop a standard for communicating complex Next Generation Sequencing (NGS) workflows opens doors for selling regulatory review tools and services to entities seeking streamlined and efficient biomedical data analysis.